Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (9): 1-7.doi: 10.6040/j.issn.1671-7554.0.2022.0916

    Next Articles

Status and progress of female fertility protection

WU Ruifang1,2,3, LI Changzhong1,2,3   

  1. 1. Center of Obstetrics &
    Gynecology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China;
    2. Institute of Obstetrics and Gynecology, Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, Guangdong, China;
    3. Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecologic Diseases, Shenzhen 518036, Guangdong, China
  • Published:2022-09-02

RichHTML

47

PDF (PC)

561

Abstract: Fertility protection, as a new and rapidly developing interdisciplinary field in recent years, has made great progress and applied fertility preservative technology(FPT)which plays important roles in preserving fertility and solving infertility problems. FPT such as in vitro cryopreservation of the eggs or ovarian tissues from young tumor patients can protect patients' fertility from disease-related damages or environmental-impacted infertility. Surgical measures with primary purpose to keep fertility can solve problems resulting in infertility and repair or reconstruct the structure and function of the reproductive organs. Assisted reproductive treatment as a complement measure can rate up the success of assisted reproduction. In this article, we will highlight the significant developments of fertility preservation, identify the challenges to be faced and put forward recommendations for the development of fertility preservative technology in China.

Key words: Oncofertility, Cancer therapies, Fertility preservation, Quality of life, Healthcare management

CLC Number: 

  • R711.6
[1] Tamrakar SR, Bastakoti R. Determinants of infertility in couples[J]. J Nepal Health Research Council, 2019, 17(1): 85-89.
[2] Zhang P. What can be learned from the Chinese experience in response to infertility[J]. Eur J Contracept Reprod Health Care, 2020, 25(4): 311-313.
[3] Melan K, Amant F, Veronique-Baudin J, et al. Fertility preservation healthcare circuit and networks in cancer patients worldwide: what are the issues?[J]. BMC Cancer, 2018, 18(1): 192. doi: 10.1186/s12885-018-4046-x.
[4] Anazodo A, Laws P, Logan S, et al. How can we improve oncofertility care for patients? a systematic scoping review of current international practice and models of care[J]. Hum Reprod Update, 2019, 25(2): 159-179.
[5] Brungardta JG, Burnsb KC, Dasgupt R. Fertility preservation in children and young adults with cancer[J]. Curr Opin Pediatr, 2022, 34(1): 48-52.
[6] Gargus E, Deans R, Anazodo A, et al. Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer[J]. J Natl Compr Canc Netw, 2018, 16(9): 1137-1149.
[7] Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers[J]. Fertil Steril, 2021, 115(5): 1102-1114.
[8] Moravek MB, Appiah LC, Anazodo A, et al. Development of a pediatric fertility preservation program: a report from the pediatric initiative network of the oncofertility consortium[J]. J Adolesc health, 2019, 64(5): 563-573.
[9] Mitchell RT, Williams SA. A fertile future: fertility preservation special series[J]. Reprod Fertil, 2022, 3(1): C1-C3.
[10] Rodriguez-Wallberg KA, Xia Hao, Marklund A, et al. Hot topics on fertility preservation for women and girls-current research, knowledge gaps, and future possibilities[J]. J Clin Med, 2021, 10(8): 1650. doi:10.3390/jcm10081650.
[11] Edimiris P, Krüssel JS. Fertility-preserving options before gonadotoxic antirheumatic therapy[J]. J Rheumatol,2021, 80: 726-732. doi.org/10.1007/s00393-021-01075-3.
[12] Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue[J]. Best Pract Res Clin Obstet Gynaecol, 2021, 70: 63-80. doi: 10.1016/j.bpobgyn.2020.06.011.
[13] Arecco L, Ruelle T, Martelli V, et al. How to protect ovarian function before and during chemotherapy?[J]. J Clin Med, 2021, 10(18): 4192. doi: 10.3390/jcm10184192.
[14] Valsamakis G, Valtetsiotis K, Charmandari E, et al. GnRH analogues as a co-treatment to therapy in women of reproductive age with cancer and fertility preservation[J]. Int J Mol Sci, 2022, 23(4): 2287. doi:10.3390/ijms23042287.
[15] Kado R, McCune WJ. Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 97-106. doi: 10.1016/j.bpobgyn.2019.10.008.
[16] Taylan E, Oktay K. Fertility preservation in gynecologic cancers[J]. Gynecol Oncol, 2019, 155(3): 522-529.
[17] Dietrich JE, Millar DM, Quint EH.Obstructive reproductive tract anomalies[J]. J Pediatr Adolesc Gynecol, 2014, 27(6): 396-402.
[18] Tielli A, Scala A, Alison M, et al. Ovarian torsion: diagnosis, surgery, and fertility preservation in the pediatric population[J]. Eur J Pediatr, 2022, 181(4): 1405-1411.
[19] Zhong SL, Zeng LP, Li H, et al. Development and evaluation of an improved laparoscopic myomectomy adopting intracapsular rotary-cut procedures[J]. Eur J Obstet Gynecol Reprod Bio, 2018, 221: 5-11. doi: 10.1016/j.ejogrb.2017.11.021.
[20] Zeng LP, Wei WX, Tang HR, et al. Introduction of intracapsular rotary-cut procedures(IRCP): a modified hysteromyomectomy procedures facilitating fertility preservation[J]. J Vis Exp, 2019, 143: doi: 10.3791/58410.
[21] Osada H, Silber S, Kakinuma T, et al. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis[J]. Reprod Biomed Online, 2011, 22(1): 94-99.
[22] Wu RF, Zeng LP, Hu QC, et al. Clinical efficacy and safety of fertility-preservative PUSH surgery for diffuse adenomyosis: evidence from a 11-year prospective investigation[J]. Preprints with Lancet, 2021. doi: 10.2139/ssrn.3916093.
[23] 子宫腺肌症伴不孕症诊疗中国专家共识编写组. 子宫腺肌病伴不孕症诊疗中国专家共识[J]. 中华生殖与避孕杂志, 2021, 41(4): 287-295.
[24] Zhang Y, Zhou XM, Zhu Y, et al. Current mechanisms of primordial follicle activation and new strategies for fertility preservation[J]. Mol Hum Rwprod, 2021, 27(2): gaab005. doi: 10.1093/molehr/gaab005.
[25] Zhang W, Nie RT, Cai YH, et al. Progress in germline stem cell transplantation in mammals and the potential usage[J]. Reprod Biol Endocrinol, 2022, 20(1): 59. doi: 10.1186/s12958-022-00930-5.
[26] Kim JM, Kim S, SH Lee. Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation[J]. Int J Mol Sci, 2021, 22(22): 12482. doi: 10.3390/ ijms222212482.
[27] Silvestris E, Palma GD, Canosa S, et al. Human ovarian cortex biobanking: a fascinating resource for fertility preservation in cancer[J]. Int J Mol Sci, 2020, 21(9): 3245. doi: 10.3390/ijms21093245.
[28] Yasmin E, Mitchell R, Lane S. Preservation of fertility in teenagers and young adults treated for haematological malignancies[J]. Lancet Haematol, 2021, 8(2): e149-e160.
[29] Strowitzki T, Bruckner T, Roesner S. Maternal and neonatal outcome and childrens development after medically assisted reproduction with in-vitro matured oocytes—a systematic review and meta-analysis[J]. Hum Reprod update, 2021, 27(3): 460-473.
[30] Dolmans MM, Amorim CA. Construction and use of artificial ovaries[J]. Reproduction, 2019, 158(5): F15-F25.
[31] Salama M, Woodruff TK. From bench to bedside: current developments and future possibilities of artificial human ovary to restore fertility[J]. Acta Obstet Gynecol Scand, 2019, 98(5): 659-664.
[32] Xiong JQ, Xue LR, Li Y, et al. Therapy of Endocrine Disease: novel protection and treatment strategies for chemotherapy-associated ovarian damage[J]. Eur J Endocrinol, 2021, 184(5): R177-R192.
[1] Guimin HAO,Zhuoye LUO,Yizhuo WANG. Ethical issues and considerations in fertility preservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 47-52.
[2] Yun LIN,Yanqiu XIE. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46.
[3] Xiangyan RUAN,Jiaojiao CHENG,Juan DU,Muqing GU. Ovarian tissue cryopreservation and preservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 24-30.
[4] Yuhua SHI,Ye PAN,Yanqiu XIE. Latest advances of embryo cryopreservation technology [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 12-18.
[5] Qun LU,Lulu ZHAO. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[6] Lei YAN,Caixin YUE,Yichun LIU. Fertility preservation in patients with endometriosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 31-34.
[7] DONG Xiaoqian, LI Guanjiang, XU Qianqian, XU Hongwei. Comparison among ERCP combined with ursodeoxycholic acid and other therapies in the treatment of choledocholithiasis complicated with cholecystolithiasis [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 59-66.
[8] ZHU Xuli, ZHOU Liang, WANG Yue, SUN Qingyun, CAO Mingya, DU Yuanjie, CAO Jinfeng, ZHAO Zhiming, HAO Guimin. Correlation analysis of freezing methods with different sperm sources and pregnancy outcomes [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 86-93.
[9] HAO Wenting, LI Jie, JING Zhengyue, ZHAO Dan, YUAN Yemin, YU Caiting, ZHOU Chengchao. Physical frailty as a mediator between sleep quality and quality of life in rural elderly with chronic diseases in Shandong Province, China [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 102-107.
[10] DENG Qingwen, LIU Wenbin. Multilevel analysis of health related quality of life of patients with cardiovascular disease and its determinants [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 115-121.
[11] JI Yongjuan, XIANG Zini, KUANG Guifang. A path analysis on the influence of burnout on quality of life among staff in two tertiary hospitals in Qingdao [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 102-107.
[12] SHI Fei, PAN Xiang, YANG Jianming. Analysis of life quality in 106 papillary thyroid carcinoma patients undergoing total thyroidectomy [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 87-92.
[13] XU Qiongqiong, GUO Xiaolei, CHU Jie, JING Zhengyue, ZHANG Xinyi, ZHOU Chengchao. Health-related quality of life and its influencing factors in type 2 diabetes patients in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 96-103.
[14] RUAN Xiangyan, CHENG Jiaojiao, DU Juan, LI Yanglu, JIN Fengyu, Alfred O. MUECK. Research progress of fertility preservation methods [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 29-34.
[15] LI Xiaojuan, DUAN Haixia. Application and key points of hysteroscopic surgery in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 38-44.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[2] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[3] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[4] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[5] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[6] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[7] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
[8] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[9] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53 -59 .
[10] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd